4
Changes in Ownership
Allogene Therapeutics, Inc. Filed Acc 0001593968-23-001008
Options or other derivatives
- Director acquired 116,120 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Mayo Stephen · Director
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-06-13 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +116,120 | 116,120 | D |
Loading xslF345X04/primary_01.xml…